the Laka catalogue

no title author date
6.07.4.60/51 Study on sustainable and resilient supply of medical radioisotopes in the EU. Therapeutic RadionuclidesJoint Research Centre, Ligtvoet, Scholten, Davé, King, Petrosova, Chiti, Goulart De Medeiros, Joerger September 2021
6.07.4.60/50 Innovatie in medische isotopenproductie zonder kernreactorLaka, H.vd Keur February 2021
6.07.4.60/49 Leveringszekerheid voor medische radionucliden - aanvullingen 2020Roobol, Rosenbaum, de Waard, RIVM December 2020
6.07.4.60/42 Marktontwikkeling en leveringszekerheid voor medische radionucliden, aanvullingRoobol, de Waard, RIVM September 2019
6.07.4.60/41 Marktontwikkeling en leveringszekerheid voor medische radionucliden Roobol, de Waard, RIVM July 2019
6.07.4.60/48 The Supply of Medical Isotopes. An Economic Diagnosis and Possible SolutionsOECD, NEA 2019
6.07.4.60/46 European Research Reactor Position Paper. Scenario for sustainable Molybdenum-99 production in EuropeCEA, NCBJ, NRG, PALLAS, RCR, SCK•CEN, TUM June 2018
6.07.4.60/38 Marktontwikkeling en leveringszekerheid voor medische isotopenRoobol, de Waard, RIVM April 2018
6.07.4.60/37 Medical isotopes. Global importance and opportunities for the Netherlands in a European context Nucleair Nederland November 2017
6.07.4.60/40 Medical isotope production using Lighthouse acceleratorJ.W.Blokker November 2017
6.07.4.60/30 Productie en gebruik van medische radio-isotopen in Nederland - Huidige situatie en toekomstverkenningRIVM, Roobol, van der Reijden, de Waard–Schalk, Bijwaard July 2017
6.07.4.60/31 Cyclotron Based Production of Technetium-99mIAEA June 2017
6.07.4.60/29 2017 Medical Isotope Supply Review: Mo/Tc Market Demand and Production Capacity Projection 2017-2022OECD, NEA April 2017
6.07.4.60/33 Medische isotopen. Belang voor de wereld en kansen voor NederlandNucleair Nederland April 2017
6.07.4.60/27 Molybdenum-99 for Medical ImagingNational Academies of Sciences September 2016
6.07.4.60/28 Ruwe schets van de problemen voor de behandeling van Nederlandse patiënten bij een plotselinge productiestop van medische isotopen in NederlandRIVM, Smetsers, Bijwaard, Roobol July 2016
6.07.4.60/36 2016 Medical Isotope Supply ReviewNEA June 2016
6.07.4.60/45 Emissions from Fission-Based Medical Isotope Production and their Effects on the International Monitoring SystemTh.W.Bowyer May 2015
6.07.4.60/32 Feasibility of Producing Molybdenum-99 on a Small Scale Using Fission of Low Enriched Uranium or Neutron Activation of Natural MolybdenumIAEA January 2015
6.07.4.60/25 Future Supply of Medical Radioisotopes for the UK Report 2014British Nuclear Medicine Society, Science & Technology Facilities Council November 2014
6.07.4.60/24 Nuclear Medicine without Nuclear Reactors or Uranium EnrichmentAAAS, Updegraff, Hoedl May 2013
6.07.4.60/23 The Supply of Medical Radioisotopes. Implementation of the HLG-MR Policy Approach. Results from a Self-assessment by the Global 99Mo/99mTc Supply ChainOECD, NEA March 2013
6.07.4.60/44 Maximum reasonable radioxenon releases from medical isotope production facilities and their effect on monitoring nuclear explosionsTh.W.Bowyer, R.kephart, P.W.Eslinger, J.Friese September 2012
6.07.4.60/21 Working materials Consultancy on Conversion planning for Mo-99 Production facilities from HEU to LEUIAEA August 2010
6.07.4.60/43 Isotopic noble gas signatures released from medical isotope production facilities- Simulations and measurementsP.Saey, Th.W.Bowyer, A.Ringbom April 2010
6.07.4.60/35 Alternatives for the production of medical isotopesGreenpeace Netherlands, Profundo, J.W.van Gelder, A.Herder March 2010
6.07.4.60/18 Report on Molybdenum 99 production for nuclear medicine 2010-2020AIPES November 2008
6.07.4.60/15Managing Patient Dose in Digital Radiology: ICRP Publication 93: Vol.34, No.1ICRP 2004
6.07.4.60/12Krebsbehandlung mit Neutronen fragwürdigKarin Wurzbacher, Umweltinstitut October 2003
6.07.4.60/10Annual Congress of European Association of Nuclear Medicine 23-27 AugustEANM'03 August 2003